SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000122
Filing Date
2021-02-03
Accepted
2021-02-03 13:00:42
Documents
12
Period of Report
2021-01-29
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K- e620250_8k-arct.htm   iXBRL 8-K 23721
  Complete submission text file 0001193805-21-000122.txt   197363

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20210129.xsd EX-101.SCH 3193
3 XBRL TAXONOMY EXTENSION SCHEMA arct-20210129_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION arct-20210129_pre.xml EX-101.PRE 22715
5 EXTRACTED XBRL INSTANCE DOCUMENT e620250_8k-arct_htm.xml XML 3632
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 21585340
SIC: 2834 Pharmaceutical Preparations